Search research articles
Contact Us
Filters
Showing results (111-120 of 210) with videos related to
Page
of 21
Sort By:
FEMS Microbiology Letters
|
February 17, 2000
Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding
R C Goldman, E R Baizman, C B Longley, et al.
Canadian Journal of Microbiology
|
February 1, 1997
Characterization of a lipopeptide-resistant strain of Candida albicans
D J Frost, M Knapp, K Brandt, et al.
The Journal of Antimicrobial Chemotherapy
|
April 9, 1998
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis
F Doucet-Populaire, J O Capobianco, D Zakula, et al.
Transactions of the Association of American Physicians
|
January 1, 1976
Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency
T A Waldmann, S Broder, R Krakauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1994
Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro
R P Ciavarra, C Goldman, K K Wen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)
B P Thornton, V Vĕtvicka, M Pitman, et al.
Translational Andrology and Urology
|
October 24, 2025
Risky business: penile prosthesis in high-risk patients
Sukhjeevan S Nijhar, Charlotte C Goldman, Joanna Orzel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1983
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage
K A Joiner, R C Goldman, C H Hammer, et al.
Infectious Disorders Drug Targets
|
April 8, 2011
Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis
Esther Vicente, Raquel Villar, Silvia Pérez-Silanes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1983
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition
K A Joiner, R C Goldman, C H Hammer, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 210) with videos related to
Sort By:
Page
of 21
FEMS Microbiology Letters
|
February 17, 2000
Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding
R C Goldman, E R Baizman, C B Longley, et al.
Canadian Journal of Microbiology
|
February 1, 1997
Characterization of a lipopeptide-resistant strain of Candida albicans
D J Frost, M Knapp, K Brandt, et al.
The Journal of Antimicrobial Chemotherapy
|
April 9, 1998
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis
F Doucet-Populaire, J O Capobianco, D Zakula, et al.
Transactions of the Association of American Physicians
|
January 1, 1976
Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency
T A Waldmann, S Broder, R Krakauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1994
Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro
R P Ciavarra, C Goldman, K K Wen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)
B P Thornton, V Vĕtvicka, M Pitman, et al.
Translational Andrology and Urology
|
October 24, 2025
Risky business: penile prosthesis in high-risk patients
Sukhjeevan S Nijhar, Charlotte C Goldman, Joanna Orzel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1983
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage
K A Joiner, R C Goldman, C H Hammer, et al.
Infectious Disorders Drug Targets
|
April 8, 2011
Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis
Esther Vicente, Raquel Villar, Silvia Pérez-Silanes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1983
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition
K A Joiner, R C Goldman, C H Hammer, et al.
Page
of 21